Tobacco and the pediatric chronic kidney disease population

Pediatric Nephrology

Volumn 30, Issue 2, 2014, Pages 235-243

  Omoloja, Abiodun ^a   Tyc, Vida L ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Kidney disease; Pediatrics; Tobacco exposure and outcomes

Indexed keywords

BIOLOGICAL MARKER; PASSIVE SMOKING;

CHRONIC KIDNEY DISEASE; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED PRACTICE; GLOMERULOSCLEROSIS; HUMAN; INTERVENTION STUDY; KIDNEY; MEDICAL CARE; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SELF REPORT; SMOKELESS TOBACCO; SMOKING; SMOKING REGULATION; TOBACCO USE; ADOLESCENT; ADVERSE EFFECTS; CHILD; CHRONIC KIDNEY FAILURE; FEMALE; MALE; PASSIVE SMOKING;

ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; RENAL INSUFFICIENCY, CHRONIC; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84926637614     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2804-9     Document Type: Review

References (88)

1. Department of Heallth and Human Services (US). How Tobacco Smoke Causes Disease: The biology and behavioral basis for smoking-attributable disease: A report of the surgeon general. Atlanta, GA: Department of Health and Human Services (US), Centers for disease Control and Prevention, National Center For Chronic Disease Prevention and Health Promation, Office on Smoking and Health, 2010.
2. Centers for Disease Control and Prevention (CDC) (2011) Current cigarette smoking prevalence among working adults-United States, 2004-2010. MMWR Morb Mortal Wkly Rep 60: 1305-1309.
3. Centers for Disease Control and Prevention (CDC) (2012) Current tobacco use among middle and high school students-United States, 2011. MMWR Morb Mortal Wkly Rep 61: 581-585.
4. de MattosAM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, Norman DJ, Becker T (2006) Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int 70: 757-764.
5. Omoloja A, Jerry-Fluker J, Ng DK, Abraham AG, Furth S, Warady BA, Mitsnefes M (2013) Secondhand smoke exposure is associated with proteinuria in children with chronic kidney disease. Pediatr Nephrol 28: 1243-1251.
6. Omoloja A, Chand D, Greenbaum L, Wilson A, Bastian V, Ferris M, Bernert J, Stolfi A, Patel H (2011) Cigarette smoking and secondhand smoking exposure in adolescents with chronic kidney disease: a study from the Midwest pediatric nephrology consortium. Nephrol Dial Transplant 26: 908-913.
7. Tyc VL, Throckmorton-Belzer L (2006) Smoking rates and the state of smoking interventions for children and adolescents with chronic illness. Pediatrics 118: e471-e487.
8. Yavuz A, Tuncer M, Gurkan A, Demirbas A, Suleymanlar G, Ersoy F, Yakupoglu G (2004) Cigarette smoking in renal transplant recipients. Transplant Proc 36: 108-110.
9. Kasiske BL, Klinger D (2000) Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11: 753-759.
10. Mc Causland FR, Brunelli SM, Waikar SS (2012) Association of smoking with cardiovascular and infection-related morbidity and mortality in chronic hemodialysis. Clin J Am Soc Nephrol 7: 1827-1835.
11. Stack AG, Murthy BV (2010) Cigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor. Semin Dial 23: 298-305.
12. Elders MJ, Perry CL, Eriksen MP, Giovino GA (1994) The report of the surgeon general: preventing tobacco use among young people. Am J Public Health 84: 543-547.
13. Centers forDisease Control and Prevention (CDC) (2008)Disparities in secondhand smoke exposure-united states, 1988-1994 and 1999-2004. MMWR Morb Mortal Wkly Rep 57: 744-747.
14. Centers for Disease Control and Prevention (CDC) (2007) Exposure to secondhand smoke among students aged 13-15 years-worldwide, 2000-2007. MMWR Morb Mortal Wkly Rep 56: 497-500.
15. Hogan SL, Vupputuri S, Guo X, Cai J, Colindres RE, Heiss G, Coresh J (2007) Association of cigarette smoking with albuminuria in the United States: the third national health and nutrition examination survey. Ren Fail 29: 133-142.
16. Maeda I, Hayashi T, Sato KK, Koh H, Harita N, Nakamura Y, Endo G, Kambe H, Fukuda K (2011) Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol 6: 2462-2469.
17. Garcia-Esquinas E, Loeffler LF, Weaver VM, Fadrowski JJ, Navas-Acien A (2013) Kidney function and tobacco smoke exposure in US adolescents. Pediatrics 131: e1415-e1423.
18. Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y (2010) Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis 56: 313-324.
19. Orth SR, Schroeder T, Ritz E, Ferrari P (2005) Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20: 2414-2419.
20. Zitt N, Kollerits B, Neyer U, Mark W, Heininger D, Mayer G, Kronenberg F, Lhotta K (2007) Cigarette smoking and chronic allograft nephropathy. Nephrol Dial Transplant 22: 3034-3039.
21. Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM (2001) Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 71: 1752-1757.
22. Jaimes EA, Tian RX, Raij L (2007) Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol 292: H76-H82.
23. Obert DM, Hua P, Pilkerton ME, Feng W, Jaimes EA (2011) Environmental tobacco smoke furthers progression of diabetic nephropathy. Am J Med Sci 341: 126-130.
24. Boor P, Casper S, Celec P, Hurbankova M, Beno M, Heidland A, Amann K, Sebekova K (2009) Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite. J Cell Mol Med 13: 4484-4491.
25. Yu CC, Lin JL, Lin-Tan DT (2004) Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol 15: 1016-1022.
26. Schwerdt G, Gordjani N, Benesic A, Freudinger R, Wollny B, Kirchhoff A, Gekle M (2006) Chloroacetaldehyde-and acroleininduced death of human proximal tubule cells. Pediatr Nephrol 21: 60-67.
27. Jaimes EA, DeMaster EG, Tian RX, Raij L (2004) Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 24: 1031-1036.
28. Orth SR, Hallan SI (2008) Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients-absence of evidence or evidence of absence? Clin J Am Soc Nephrol 3: 226-236.
29. Le-Ha C, Beilin LJ, Burrows S, Huang RC, Oddy WH, Hands B, Mori TA (2013) Gender difference in the relationship between passive smoking exposure and HDL-cholesterol levels in late adolescence. J Clin Endocrinol Metab 98: 2126-2135.
30. Feldman J, Shenker IR, Etzel RA, Spierto FW, Lilienfield DE, Nussbaum M, Jacobson MS (1991) Passive smoking alters lipid profiles in adolescents. Pediatrics 88: 259-264.
31. Wilkinson JD, Lee DJ, Arheart KL (2007) Secondhand smoke exposure and C-reactive protein levels in youth. Nicotine Tob Res 9: 305-307.
32. Pijanowska M, Zajaczkowska M (2004) Passive smoking and patterns of 24-hour ambulatory blood pressure in healthy children. Pol Merkur Lekarski 16: 320-322.
33. Simonetti GD, Schwertz R, KlettM, Hoffmann GF, Schaefer F, Wuhl E (2011) Determinants of blood pressure in preschool children: the role of parental smoking. Circulation 123: 292-298.
34. Kallio K, Jokinen E, Hamalainen M, Saarinen M, Volanen I, Kaitosaari T, Viikari J, Ronnemaa T, Simell O, Raitakari OT (2009) Decreased aortic elasticity in healthy 11-year-old children exposed to tobacco smoke. Pediatrics 123: e267-e273.
35. Kallio K, Jokinen E, Raitakari OT, Hamalainen M, Siltala M, Volanen I, Kaitosaari T, Viikari J, Ronnemaa T, Simell O (2007) Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation 115: 3205-3212.
36. Makris TK, Thomopoulos C, Papadopoulos DP, Bratsas A, Papazachou O, Massias S, Michalopoulou E, Tsioufis C, Stefanadis C (2009) Association of passive smoking with masked hypertension in clinically normotensive nonsmokers. AmJ Hypertens 22: 853-859.
37. Barnoya J, Glantz SA (2005) Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 111: 2684-2698.
38. Holmberg T, BechM, Curtis T, JuelK, GronbaekM, Brixen K (2011) Association between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study-the Danish health examination survey 2007-2008. Osteoporos Int 22: 2989-2999.
39. Blum M, Harris SS, Must A, Phillips SM, Rand WM, Dawson-Hughes B (2002) Household tobacco smoke exposure is negatively associated with premenopausal bone mass. Osteoporos Int 13: 663-668.
40. Yolton K, Dietrich K, Auinger P, Lanphear BP, Hornung R (2005) Exposure to environmental tobacco smoke and cognitive abilities among U. S. children and adolescents. Environ Health Perspect 113: 98-103.
41. Collins BN, Wileyto EP, Murphy MF, Munafo MR (2007) Adolescent environmental tobacco smoke exposure predicts academic achievement test failure. J Adolesc Health 41: 363-370.
42. Hooper SR, Gerson AC, Butler RW, Gipson DS, Mendley SR, Lande MB, Shinnar S, Wentz A, Matheson M, Cox C, Furth SL, Warady BA (2011) Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease. Clin J Am Soc Nephrol 6: 1824-1830.
43. Omoloja A, AbrahamA, MathesonM, Mitsnefes M, Furth S, Warady B, Gerson AC (2012) Association between second-hand smoking exposure, neurocognitive functioning and HRQoL in children with CKD. E-PAS2012: 2910. 138.
44. Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande MB, Shinnar S, Moxey-Mims MM, Warady BA, Furth SL (2010) Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics 125: e349-e357.
45. Weeks SG, Glantz SA, De Marco T, Rosen AB, Fleischmann KE (2011) Secondhand smoke exposure and quality of life in patients with heart failure. Arch Intern Med 171: 1887-1893.
46. Bridevaux PO, Cornuz J, Gaspoz JM, Burnand B, Ackermann-Liebrich U, Schindler C, Leuenberger P, Rochat T, Gerbase MW, SAPALDIA Team (2007) Secondhand smoke and health-related quality of life in never smokers: results from the SAPALDIA cohort study 2. Arch Intern Med 167: 2516-2523.
47. Dube SR, ThompsonW, Homa DM, ZackMM (2013) Smoking and health-related quality of life among U. S. adolescents. Nicotine Tob Res 15: 492-500.
48. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN (2000) Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 36: 167-176.
49. Kroon LA (2007) Drug interactions with smoking. Am J Health Syst Pharm 64: 1917-1921.
50. Schein JR (1995) Cigarette smoking and clinically significant drug interactions. Ann Pharmacother 29: 1139-1148.
51. Agaku IT, Ayo-Yusuf OA, Vardavas CI, Alpert HR, Connolly GN (2013) Use of conventional and novel smokeless tobacco products among US adolescents. Pediatrics 132: E578-E586.
52. Agaku IT, Vardavas CI, Ayo-Yusuf OA, Alpert HR, Connolly GN (2013) Temporal trends in smokeless tobacco use among US middle and high school students, 2000-2011. JAMA 309: 1992-1994.
53. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W (2007) Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med 262: 351-359.
54. Hergens MP, Lambe M, Pershagen G, Terent A, Ye W (2008) Smokeless tobacco and the risk of stroke. Epidemiology 19: 794-799.
55. Hergens MP, Lambe M, Pershagen G, Ye W (2008) Risk of hypertension amongst Swedish male snuff users: a prospective study. J Intern Med 264: 187-194.
56. Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B (2011) Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol 6: 218-226.
57. Avila-Tang E, Al-DelaimyWK, Ashley DL, Benowitz N, Bernert JT, Kim S, Samet JM, Hecht SS (2013) Assessing secondhand smoke using biological markers. Tob Control 22: 164-171.
58. Benowitz NL, Hukkanen J, Jacob P 3rd (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 192: 29-60.
59. Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R (2000) Pharmacokinetics of nicotine in kidney failure. Clin Pharmacol Ther 68: 250-260.
60. Nguyen PT, Galanti L, Pirson Y, Jadoul M (2007) Identification of current smokers among renal transplant recipients. Nephrol Dial Transplant 22: 1974-1978.
61. Matt GE, Hovell MF, Quintana PJ, Zakarian J, Liles S, Meltzer SB, Benowitz NL (2007) The variability of urinary cotinine levels in young children: implications for measuring ETS exposure. Nicotine Tob Res 9: 83-92.
62. Committee on Environmental HealthHealth, Committee on Substance Abuse, Committee on Adolescence, & Committee on Native American Child (2009) From the American academy of pediatrics: policy statement-tobacco use: a pediatric disease. Pediatrics 124: 1474-1487.
63. Bartecchi CE, MacKenzie TD, Schrier RW (1994) The human costs of tobacco use (1). N Engl J Med 330: 907-912.
64. Farkas AJ, Gilpin EA, White MM, Pierce JP (2000) Association between household and workplace smoking restrictions and adolescent smoking. JAMA 284: 717-722.
65. WakefieldMA, Chaloupka FJ, Kaufman NJ, Orleans CT, Barker DC, Ruel EE (2000) Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ 321: 333-337.
66. Choi WS, Gilpin EA, Farkas AJ, Pierce JP (2001) Determining the probability of future smoking among adolescents. Addiction 96: 313-323.
67. DiFranza JR, Savageau JA, Fletcher K, O'Loughlin J, Pbert L, Ockene JK, McNeill AD, Hazelton J, Friedman K, Dussault G, Wood C, Wellman RJ (2007) Symptoms of tobacco dependence after brief intermittent use: the development and assessment of nicotine dependence in youth-2 study. Arch Pediatr Adolesc Med 161: 704-710.
68. Ursprung WW, DiFranza JR (2010) The loss of autonomy over smoking in relation to lifetime cigarette consumption. Addict Behav 35: 14-18.
69. Bruner K, Chand D, Patel H, Stolfi A, Omoloja A (2011) Chronic kidney disease, pediatric nephrologists, and tobacco counseling: perceptions and practice patterns. A study from the midwest pediatric nephrology consortium. J Pediatr 159: 155-157.
70. Ehlers SL, Rodrigue JR, Patton PR, Lloyd-Turner J, Kaplan B, Howard RJ (2006) Treating tobacco use and dependence in kidney transplant recipients: development and implementation of a program. Prog Transplant 16: 33-37.
71. Patnode CD, O'Connor E, Whitlock EP, Perdue LA, Soh C, Hollis J (2013) Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U. S. preventive services task force. Ann Intern Med 158: 253-260.
72. Rosen LJ, Noach MB, Winickoff JP, Hovell MF (2012) Parental smoking cessation to protect young children: a systematic review and meta-analysis. Pediatrics 129: 141-152.
73. Priest N, Roseby R, Waters E, Polnay A, Campbell R, Spencer N, Webster P, Ferguson-Thorne G (2008) Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke. Cochrane Database Syst Rev (4): CD001746. doi: 10. 1002/14651858. CD001746. pub2.
74. Hovell MF, Meltzer SB, Zakarian JM, Wahlgren DR, Emerson JA, Hofstetter CR, Leaderer BP, Meltzer EO, Zeiger RS, O'Connor RD (1994) Reduction of environmental tobacco smoke exposure among asthmatic children: a controlled trial. Chest 106: 440-446.
75. HovellMF, Zakarian JM, Matt GE, Hofstetter CR, Bernert JT, Pirkle J (2000) Effect of counselling mothers on their children's exposure to environmental tobacco smoke: Randomised controlled trial. BMJ 321: 337-342.
76. Hovell MF, Meltzer SB, Wahlgren DR, Matt GE, Hofstetter CR, Jones JA, Meltzer EO, Bernert JT, Pirkle JL (2002) Asthma management and environmental tobacco smoke exposure reduction in Latino children: a controlled trial. Pediatrics 110: 946-956.
77. Emmons KM, Hammond SK, Fava JL, Velicer WF, Evans JL, Monroe AD (2001) A randomized trial to reduce passive smoke exposure in low-income households with young children. Pediatrics 108: 18-24.
78. Tyc VL, Huang Q, Nicholson J, Schultz B, Hovell MF, Lensing S, Vukadinovich C, Hudson MM, Zhang H (2013) Intervention to reduce secondhand smoke exposure among children with cancer: a controlled trial. Psychooncology 22: 1104-1111.
79. Winickoff JP, Buckley VJ, Palfrey JS, Perrin JM, Rigotti NA (2003) Intervention with parental smokers in an outpatient pediatric clinic using counseling and nicotine replacement. Pediatrics 112: 1127-1133.
80. Winickoff JP, Tanski SE, McMillen RC, Hipple BJ, Friebely J, Healey EA (2006) A national survey of the acceptability of quit lines to help parents quit smoking. Pediatrics 117: e695-e700.
81. Winickoff JP, Tanski SE, McMillen RC, Klein JD, Rigotti NA, Weitzman M (2005) Child health care clinicians' use of medications to help parents quit smoking: a national parent survey. Pediatrics 115: 1013-1017.
82. Cluss PA, Moss D (2002) Parent attitudes about pediatricians addressing parental smoking. Ambul Pediatr 2: 485-488.
83. Moss D, Cluss PA, Mesiano M, Kip KE (2006) Accessing adult smokers in the pediatric setting: what do parents think? Nicotine Tob Res 8: 67-75.
84. Winickoff JP, Hibberd PL, Case B, Sinha P, Rigotti NA (2001) Child hospitalization: an opportunity for parental smoking intervention. Am J Prev Med 21: 218-220.
85. Epps RP, Manley MW (1991) A physicians's guide to preventing tobacco use during childhood and adolescence. Pediatrics 88: 140-144.
86. Tyc VL, Rai SN, Lensing S, Klosky JL, StewartDB, Gattuso J (2003) Intervention to reduce intentions to use tobacco among pediatric cancer survivors. J Clin Oncol 21: 1366-1372.
87. Klosky JL, Tyc VL, Hum A, Lensing S, Buscemi J, Garces-Webb DM, Hudson MM (2010) Establishing the predictive validity of intentions to smoke among preadolescents and adolescents surviving cancer. J Clin Oncol 28: 431-436.
88. Hoving C, Reubsaet A, de Vries H (2007) Predictors of smoking stage transitions for adolescent boys and girls. Prev Med 44: 485-489.